Tag: Accendra Health
Accendra Health announces exchange offer, consent solicitations
May 26, 2026HME News Staff
RICHMOND, Va. – Accendra Health has commenced an offer to exchange any and all of the company’s outstanding 4.5% senior notes due 2029 and 6.625% senior notes due 2030. Eligible holders of 2029 notes that participate in the new money notes issuance will be able to exchange such 2029 notes for newly issued 9% senior secured first lien notes due 2032 and newly issued 9.75% senior secured second lien notes due 2033. Eligible holders of 2029 notes that do not participate in the new money...
In brief: Scam prevention, PBM protection, Accendra offer
May 22, 2026HME News Staff
WASHINGTON – Rep. Aaron Bean, R-Fla., has introduced H.R. 8871, the DME Scammer Prevention Act, to require the electronic submission of DME products most susceptible to fraud within 90 days of the initial claim date. The current submission deadline is 365 days, which Bean says allows fraudulent vendors to take advantage of the payment system. “Rising fraud and criminal activity threaten to undermine the Medicare system for Northeast Floridians and seniors across the country,” he...
Accendra Health reports Q1, announces $1.5B optimization
May 11, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported $627.8 million for the first quarter of 2026 vs. $673.9 million for the same period last year. Adjusted EBITDA was $58.4 million vs. $96 million.
Unless otherwise noted, the results reflect Accendra’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. The company ended the fourth quarter of 2025 by selling its Products & Healthcare Services (P&HS) business to Platinum...
Accendra Health bets on Optum contract, leaner structure
February 20, 2026Theresa Flaherty, Managing Editor
RICHMOND, Va. – With the sale of its Products & Healthcare Services (P&HS) segment behind it, Accendra Health is entering 2026 as a more “nimble” company, say execs.
New focus brings fresh start
The company on Dec. 31 completed the sale of its Products & Healthcare Services (P&HS) business to Platinum Equity for $375 million, and began operating under the name Accendra Health.
“We're...
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’
February 20, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported revenue of $709 million for the fourth quarter ended Dec. 31, 2025.
For the full year 2025, it reported $2.8 billion, representing 3% growth vs. prior year. Results, unless otherwise noted, reflect the company’s Patient Direct business, said executives.
The company ended the fourth quarter with the completion of the sale of its Products & Healthcare Services (P&HS) business on Dec. 31, 2025, to Platinum Equity for $375 million, and began...
It’s official: Accendra Health goes live on NYSE, unveils new website
January 5, 2026HME News Staff
RICHMOND, Va. – Accendra Health began trading on the New York Stock Exchange on Jan. 2 under the ticker symbol ACH. The company also launched a new website: www.accendrahealth.com. This follows the completion of the sale of its former Products & Healthcare Services business and the transition away from its Owens & Minor brand. Accendra Health has said the name change affects only the name of the parent corporation and is intended to...
In brief: Accendra executive changes, BFLOW’s anniversary, Re-Time's smart ring
January 2, 2026HME News Staff
RICHMOND, Va. – Owens & Minor, now operating as Accendra Health, has announced the departure of two executives in connection with the sale of its Products & Healthcare Services, which closed Dec. 31. Andrew G. Long, executive vice president, CEO of Products & Healthcare Services, and Michael Lowry, senior vice president, corporate controller and chief accounting officer have left the company. Jonathan Leon, executive vice president & CFO since September...
Owens & Minor to kick off new year with new name: Accendra Health
December 18, 2025HME News Staff
RICHMOND, Va. – Owens & Minor, Inc. will change its name to Accendra Health, Inc. with an anticipated effective date of Dec. 31.
The name change affects only the name of the parent corporation and is intended to better reflect the company’s strategic direction and future organizational focus as a leader in the home-based care market. The company will continue to use and operate under the Apria and Byram Healthcare brands.
Earlier this year,...